STUDY PERIOD
Start date: November 5, 2021
End date: July 2024
STUDY INFORMATION
Indication: This study is developed to evaluate the effect of Add-on Therapy in patients with Hypertension
Frequency of Visit:
Screening Visit: 1
In Person Visit: 17
Run-In Visit: 2
STUDY CRITERIA
Age: 18 to 75 years old
Gender: Both
